Comparative Effectiveness: Implications for Plans, Providers and Other Stakeholders

Comparative Effectiveness:
Implications for Plans, Providers and Other Stakeholders

Tuesday, August 25th, 2009
1:00 p.m. to 2:00 p.m. Eastern (10:00 - 11:00 a.m. Pacific)
Click here to find out what time your event starts in your time zone.

Implications for Plans, Providers, Pharma & Government
How Better Cost/Benefit Evidence of Treatment Options Can Reduce Costs and Improve Health

Register for $195
Call 209.577.4888 or
Click here to register

Review of the current state of comparative effectiveness research in U.S. health care
Different models of comparative effectiveness used in developed health systems.
Key lessons from abroad that demonstrate the complexity of implementation in the U.S.
Implementation Realities including the status of applicable health reform initiatives

	Faculty: Paul Keckley, Executive Director of the Deloitte Center for Health Solutions Deloitte LLP

Comparative effectiveness has been one of the most contentious issues in health reform. Recent legislative initiatives and current health reform proposals have moved comparative effectiveness to the forefront of attention for health care stakeholders, with a broad range of complexities and implications.

Generating better evidence about the costs and benefits of different treatment options – through research on the comparative effectiveness of those options – has the potential to bend the curve in health care spending and reduce inappropriate variation in the system.

Join Paul Keckley, Executive Director of the Deloitte Center for Health Solutions, Deloitte LLP, in an examination of comparative effectiveness implications for a variety of stakeholders, including policy makers, providers, consumers, payors/health plans, and life sciences companies, based upon the recent Deloitte Center for Health Solutions study: "Comparative Effectiveness: Perspectives for Consideration." Report findings conclude that, in the U.S., a “tools, not rules” approach, with industry and policy makers working side by side, will result in a comparative effectiveness model that delivers better value and lower costs.

This session addresses:

Review of the current state of comparative effectiveness research in U.S. health care
Examination of different models of comparative effectiveness used in developed health systems.
Discussion of key lessons from abroad that demonstrate the complexity of implementation in the U.S.
Realities of implementing comparative effectiveness in the U.S., including the status of health reform efforts to advance comparative effectiveness.
Implications for plans, providers, life science organizations and government.
How better evidence about the costs and benefits of different treatment options can help reduce health-care spending without adversely affecting health.

Interested attendees would include:

C-Suite Executives
Medical Directors
Care Management Executives and Staff
Policy Executives and Staff
Strategy and Planning Executives and Staff
Health Care Analytics Executives
Other Interested Parties

Attendees would represent organizations including

Health Plans
Hospitals
Life Science Organizations
Medical Groups
Provider Networks
Employers
Third Party Administrators
PBMs
Care Management Organizations
Solutions Providers
Associations, Institutes and Research Organizations
State and Local Government
Media

Individual Registration Fee: $195. Audio Conference CD-ROM: $40 for attendees; $255 for non-attendees after the event.

Corporate Site licensing also available. Click here to register or call 209.577.4888 We look forward to your participation in this event!

Paul Keckley
Executive Director of the Deloitte Center for Health Solutions, Deloitte LLP

Paul H. Keckley, Ph.D., is the executive director of the Deloitte Center for Health Solutions (the Center), a part of Deloitte LLP (Deloitte). He provides strategic guidance on the development of Center research and thought leadership. Paul has had 30 years of experience in academic medicine and the private sector. He is well-regarded for his knowledge of health care economics, health policy and trend analysis.

Prior to joining Deloitte, Paul served in several key roles at Vanderbilt University. He was the executive director of the Vanderbilt Center for Evidence-based Medicine (VCEBM), associate professor at Vanderbilt University School of Medicine and an associate professor of Health Management at the Owen Graduate School of Business. He oversaw many clinical outsourcing ventures involving care team training, clinical information technology, data management, and evidence-based pathway construction and integration. Paul also has engaged in several joint ventures, including specialty hospitals in the United Kingdom, development of primary care delivery systems in Botswana, partnerships with two Fortune 100 companies pursuing innovative approaches to chronic care management and others that are in early-stage development.

Paul supported efforts by the Vanderbilt Medical Group to develop, integrate and measure adherence to evidence-based pathways and order sets. He also was instrumental in spearheading Vanderbilt’s entry into integrative health, with the Vanderbilt Center for Integrative Health.

Before joining Vanderbilt, Paul served as chairman of the board of a large California dental practice management company; chief executive officer (CEO) of an enterprise business management solutions firm; a developer of evidence-based guideline software; CEO of a community medical management firm and principal of The Keckley Group, a strategic planning consulting practice that served 1,200 U.S. provider organizations and health plans.

Paul is an active member of several societies and editorial boards, and has authored numerous articles and three books. He has been profiled by ABC’s "20/20," CBS’s "60 Minutes," CNN, Fox News and The Wall Street Journal; he also has been a keynote speaker at several national industry meetings. Paul has testified for state Medicaid Review Committees in Utah and Tennessee about the potential impact of evidence-based standards on benefits for enrollees.

He received a bachelor of arts degree from Lipscomb University, a master's degree and a doctorate degree from Ohio State University, and he completed a fellowship in economic policy at Oxford University.

1101 Standiford Ave. Suite C-3 Modesto, CA 95350 Phone 209.577.4888 | e-Mail infohws@healthwebsummit.com | Fax 209.577.3557